Cargando…
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium
BACKGROUND: Pseudomonas aeruginosa airway infections are a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Azithromycin improves the related clinical outcomes, but its mechanisms of action remain poorly understood. We tested the hypothesis that azithromycin downregulate...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108761/ https://www.ncbi.nlm.nih.gov/pubmed/27895643 http://dx.doi.org/10.3389/fimmu.2016.00499 |
_version_ | 1782467413957148672 |
---|---|
author | Leal, Teresinha Bergamini, Gabriella Huaux, François Panin, Nadtha Noel, Sabrina Dhooghe, Barbara Haaf, Jeremy B. Mauri, Pierluigi Motta, Sara Di Silvestre, Dario Melotti, Paola Sorio, Claudio |
author_facet | Leal, Teresinha Bergamini, Gabriella Huaux, François Panin, Nadtha Noel, Sabrina Dhooghe, Barbara Haaf, Jeremy B. Mauri, Pierluigi Motta, Sara Di Silvestre, Dario Melotti, Paola Sorio, Claudio |
author_sort | Leal, Teresinha |
collection | PubMed |
description | BACKGROUND: Pseudomonas aeruginosa airway infections are a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Azithromycin improves the related clinical outcomes, but its mechanisms of action remain poorly understood. We tested the hypothesis that azithromycin downregulates P. aeruginosa-induced pro-inflammatory responses by modifying release of bacterial proteins. METHODS: We monitored inflammatory markers in lungs of CF mutant mice and their littermate controls in response to conditioned media (CM) collected from the reference P. aeruginosa PAO1 strain cultured in the presence or in the absence of azithromycin. A mass spectrometry-based proteomic approach was applied to examine whether the macrolide elicits a differential release of bacterial proteins. RESULTS: CM collected from azithromycin-untreated PAO1 cultures induced powerful pro-inflammatory neutrophil-dominated responses. Azithromycin attenuated the responses, mainly of macrophage chemoattractant protein-1, tumor necrosis factor-α, and interferon-γ, in CF but not in wild-type mice. Proteomic analysis showed that azithromycin upregulated an array of bacterial proteins including those associated with regulation of immune functions and with repair and resolution of inflammatory responses like the chaperone DnaK and the S-adenosylmethionine synthase, while it downregulated the extracellular heme acquisition protein HasA and the catalytic enzyme lysylendopeptidase. CONCLUSION: Supernatants collected from cultures of the bacterial strain PAO1 represent a novel experimental model to trigger in vivo lung inflammatory responses that should be closer to those obtained with live bacteria, but without bacterial infection. Combined with a bactericidal effect, complex regulation of bacterial innate immune and metabolic factors released in the cultured medium by the action of the macrolide can contribute to its anti-inflammatory effects. |
format | Online Article Text |
id | pubmed-5108761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51087612016-11-28 Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium Leal, Teresinha Bergamini, Gabriella Huaux, François Panin, Nadtha Noel, Sabrina Dhooghe, Barbara Haaf, Jeremy B. Mauri, Pierluigi Motta, Sara Di Silvestre, Dario Melotti, Paola Sorio, Claudio Front Immunol Immunology BACKGROUND: Pseudomonas aeruginosa airway infections are a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Azithromycin improves the related clinical outcomes, but its mechanisms of action remain poorly understood. We tested the hypothesis that azithromycin downregulates P. aeruginosa-induced pro-inflammatory responses by modifying release of bacterial proteins. METHODS: We monitored inflammatory markers in lungs of CF mutant mice and their littermate controls in response to conditioned media (CM) collected from the reference P. aeruginosa PAO1 strain cultured in the presence or in the absence of azithromycin. A mass spectrometry-based proteomic approach was applied to examine whether the macrolide elicits a differential release of bacterial proteins. RESULTS: CM collected from azithromycin-untreated PAO1 cultures induced powerful pro-inflammatory neutrophil-dominated responses. Azithromycin attenuated the responses, mainly of macrophage chemoattractant protein-1, tumor necrosis factor-α, and interferon-γ, in CF but not in wild-type mice. Proteomic analysis showed that azithromycin upregulated an array of bacterial proteins including those associated with regulation of immune functions and with repair and resolution of inflammatory responses like the chaperone DnaK and the S-adenosylmethionine synthase, while it downregulated the extracellular heme acquisition protein HasA and the catalytic enzyme lysylendopeptidase. CONCLUSION: Supernatants collected from cultures of the bacterial strain PAO1 represent a novel experimental model to trigger in vivo lung inflammatory responses that should be closer to those obtained with live bacteria, but without bacterial infection. Combined with a bactericidal effect, complex regulation of bacterial innate immune and metabolic factors released in the cultured medium by the action of the macrolide can contribute to its anti-inflammatory effects. Frontiers Media S.A. 2016-11-15 /pmc/articles/PMC5108761/ /pubmed/27895643 http://dx.doi.org/10.3389/fimmu.2016.00499 Text en Copyright © 2016 Leal, Bergamini, Huaux, Panin, Noel, Dhooghe, Haaf, Mauri, Motta, Di Silvestre, Melotti and Sorio. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Leal, Teresinha Bergamini, Gabriella Huaux, François Panin, Nadtha Noel, Sabrina Dhooghe, Barbara Haaf, Jeremy B. Mauri, Pierluigi Motta, Sara Di Silvestre, Dario Melotti, Paola Sorio, Claudio Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium |
title | Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium |
title_full | Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium |
title_fullStr | Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium |
title_full_unstemmed | Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium |
title_short | Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium |
title_sort | azithromycin attenuates pseudomonas-induced lung inflammation by targeting bacterial proteins secreted in the cultured medium |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108761/ https://www.ncbi.nlm.nih.gov/pubmed/27895643 http://dx.doi.org/10.3389/fimmu.2016.00499 |
work_keys_str_mv | AT lealteresinha azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT bergaminigabriella azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT huauxfrancois azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT paninnadtha azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT noelsabrina azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT dhooghebarbara azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT haafjeremyb azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT mauripierluigi azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT mottasara azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT disilvestredario azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT melottipaola azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium AT sorioclaudio azithromycinattenuatespseudomonasinducedlunginflammationbytargetingbacterialproteinssecretedintheculturedmedium |